Neovastat (AE-941) in Refractory and Early Relapse Multiple Myeloma Patients
Phase of Trial: Phase II
Latest Information Update: 27 Feb 2013
At a glance
- Drugs AE 941 (Primary)
- Indications Multiple myeloma
- Focus Therapeutic Use
- 07 Feb 2008 Status changed from in progress to completed.
- 04 Oct 2005 New trial record.